Growth factors in retinal diseases: proliferative vitreoretinopathy, proliferative diabetic retinopathy, and retinal degeneration.
about
Proliferative vitreoretinopathyProliferative vitreoretinopathy: current and emerging treatmentsTransforming growth factor-β regulates the expression of anosmin (KAL-1) in human retinal pigment epithelial cellsTumor necrosis factor-alpha regulates transforming growth factor-beta-dependent epithelial-mesenchymal transition by promoting hyaluronan-CD44-moesin interaction.Apelin in epiretinal membranes of patients with proliferative diabetic retinopathy.Lutein inhibits the migration of retinal pigment epithelial cells via cytosolic and mitochondrial Akt pathways (lutein inhibits RPE cells migration).Enhanced PKCδ and ERK signaling mediate cell migration of retinal pigment epithelial cells synergistically induced by HGF and EGF.The T309G MDM2 gene polymorphism is a novel risk factor for proliferative vitreoretinopathy.Clinical and histological characteristics of canine ocular gliovascular syndrome.Pars plana vitrectomy assisted by triamcinolone acetonide for refractory uveitis: a case series studyTransforming growth factor-β neutralizing antibodies inhibit subretinal fibrosis in a mouse modelNeuron-specific TGF-beta signaling deficiency results in retinal detachment and cataracts in miceRek, a gene expressed in retina and brain, encodes a receptor tyrosine kinase of the Axl/Tyro3 family.Nimodipine rescues N-methyl-N-nitrosourea-induced retinal degeneration in ratsProliferative vitreoretinopathy after eye injuries: an overexpression of growth factors and cytokines leading to a retinal keloidOnset and recurrence of proliferative vitreoretinopathy in various vitreoretinal diseaseUpregulated expression of vascular endothelial growth factor in proliferative diabetic retinopathy.Disease pathways in proliferative vitreoretinopathy: an ongoing challenge.Expression of intercellular adhesion molecule-1 (ICAM-1) and vascular cell adhesion molecule-1 (VCAM-1) on proliferating vascular endothelial cells in diabetic epiretinal membranesProinflammatory effect of TWEAK/Fn14 interaction in human retinal pigment epithelial cells.The role of growth factors in proliferative diabetic retinopathy.Differential cytokine expression of human retinal pigment epithelial cells in response to stimulation by C5a.The treatment of vitreoretinal scar tissue.SV40-immortalized and primary cultured human retinal pigment epithelial cells share similar patterns of cytokine-receptor expression and cytokine responsiveness.Enhancement of dedifferentiation and myoid differentiation of retinal pigment epithelial cells by platelet derived growth factor.Regulation of plasminogen activation by TGF-beta in cultured human retinal endothelial cellsComparison of the levels of hepatocyte growth factor and vascular endothelial growth factor in aqueous fluid and serum with grades of retinopathy in patients with diabetes mellitus.Vascular endothelial growth factor and hepatocyte growth factor levels are differentially elevated in patients with advanced retinopathy of prematurity.Lipid factor (bVLF) from bovine vitreous body evokes in EGFR-T17 cells a Ca2+-dependent K+ current associated with inositol 1,4,5-trisphosphate-independent Ca2+ mobilization.Gene transfer of soluble TGF-beta type II receptor inhibits experimental proliferative vitreoretinopathy.Enzyme-assisted vitrectomy in enucleated pig eyes: a comparison of hyaluronidase, chondroitinase, and plasmin.Herpes simplex virus entry receptor nectin-1 is widely expressed in the murine eye.The bovine vitreous-derived lipid factor (bVLF) is a powerful inhibitor of retinal pigmented epithelial (hRPE) cell proliferation.Stromal-derived factor-1 and inflammatory cytokines in retinal vein occlusion.Histopathological and ophthalmoscopic evaluation of apocynin on experimental proliferative vitreoretinopathy in rabbit eyes.Myofibroblast transdifferentiation: The dark force in ocular wound healing and fibrosis.Expression of transforming growth factor-beta s and their receptors by human retinal glial cells.Experimental model for proliferative vitreoretinopathy by intravitreal dispase: limited by zonulolysis and cataract.Experimental Modeling of Proliferative Vitreoretinopathy. An Experimental Morphological Study.
P2860
Q24563110-1B838020-C102-4E7D-8121-527C74E37CBEQ28274083-E391F334-0247-47CD-AE5F-ED112E1F020CQ28284423-82D63043-160E-42EA-9BA4-49CE4876BB5AQ30493184-AAE1C1EC-4E7C-40F8-AADD-339E797C9DC0Q33990716-61029344-AD85-4800-A478-2E809B1AC0DDQ34158448-D7C6FB59-06F7-4116-85E3-DD39276BAC70Q34427717-1D570F95-0BBB-4BDE-A915-356C33D833CCQ35070151-A5979C9E-7DC8-4E3A-8AD4-8B8130B25742Q35235652-F42989EE-BCE8-4974-862D-01BDEAF5A0C3Q35591314-48CE4370-942A-44F4-A53C-2858741AE55CQ36072357-037D562E-D595-4758-9A5F-9EE6EE1B0170Q36113956-77D2AB63-08A1-4B13-B1B5-0D95BE2074C7Q36831517-2322DEFB-98C1-408B-A96B-4525520F5EDCQ36924251-032FA236-6403-4597-9986-E68177396F19Q37250122-3E0604F3-6D2B-4EF3-BD63-4731E36ED234Q37315556-2653E1D3-0335-4F91-AE8F-2C3E3473FE1EQ37318959-3129E149-072E-4C18-AB45-C2242BC77FF9Q38194096-41D4A835-F85B-449C-9121-41E75382CB91Q39701177-821B29B6-3E33-47A7-BEB7-BC778C685912Q39778302-D5E396B4-6007-4C00-8010-D70A67C89135Q40442587-C8E2191F-6B21-46FA-8866-2888D9BFA13DQ40673512-FED085EE-E9FE-4D57-8338-7BC6D3033166Q41052869-407130C5-2C67-4283-8BE2-4BB16D802FB8Q41342343-559DB116-3A30-4E24-9667-9D1927AAFFF4Q41823456-26E4FC9C-6003-4319-8D70-FF43CBAB4FA9Q41947979-80168A9D-1041-4E8A-8CD5-F2D46401D76FQ42698660-C2B6BC03-15A1-479D-A78D-90E0A6AC203EQ42775475-0E839D27-0FE1-4E7F-BD8B-8B8D2C4C8AFCQ42804893-3EA9BEDE-AF7C-4FAC-B51E-4A461C3A08EBQ44128315-F171B319-F6C9-4C18-B752-1749759F7FC7Q45182169-B9442AD4-597D-4A31-9343-E376ADF916EBQ45537733-3E9F73BC-C643-41A4-98ED-77DD815D4334Q46590641-DD1564E3-5752-4D09-9F96-8193ABC19606Q46846450-DC66098C-9A45-4067-8874-CE6D4902611EQ47401527-405B6794-9852-403C-ADC5-E855F65C9B04Q47954026-F6DCE436-8D4D-45FC-B982-3E3E99A610F9Q48002500-0C9194DE-351D-4746-89FD-43C867748FCDQ48689911-D0769032-FC32-4AD8-B351-1D66D8BB0046Q53483577-8DDE2502-4E02-4992-967E-01BADE79CDA1
P2860
Growth factors in retinal diseases: proliferative vitreoretinopathy, proliferative diabetic retinopathy, and retinal degeneration.
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年学术文章
@wuu
1992年学术文章
@zh-cn
1992年学术文章
@zh-hans
1992年学术文章
@zh-my
1992年学术文章
@zh-sg
1992年學術文章
@yue
1992年學術文章
@zh
1992年學術文章
@zh-hant
name
Growth factors in retinal dise ...... thy, and retinal degeneration.
@ast
Growth factors in retinal dise ...... thy, and retinal degeneration.
@en
type
label
Growth factors in retinal dise ...... thy, and retinal degeneration.
@ast
Growth factors in retinal dise ...... thy, and retinal degeneration.
@en
prefLabel
Growth factors in retinal dise ...... thy, and retinal degeneration.
@ast
Growth factors in retinal dise ...... thy, and retinal degeneration.
@en
P1476
Growth factors in retinal dise ...... thy, and retinal degeneration.
@en
P2093
Wiedemann P
P304
P356
10.1016/0039-6257(92)90115-A
P577
1992-03-01T00:00:00Z